Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.25 SEK | +0.92% | +12.83% | -26.44% |
05-15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENOVIS AB | Diagnostic & Testing Substances | +0.92% | +12.83% | -26.44% | -25.87% | +112.50% | 238M |
Technical Rankings Surperformance
- Stock Market
- Equities
- GENO Stock
- Charts Genovis AB
- Comparison Chart